Researchers have introduced a new type of vaccine entirely designed by artificial intelligence (AI), marking the world's first such vaccine. Human trials have begun, with hopes to protect against all coronavirus variants as well as animal viruses that might trigger future pandemics.
On 5 June 2026 GMT+7, a research team from the University of Cambridge in England announced their success in developing a new vaccine using AI technology to design all key components. This vaccine has entered human trials for the first time worldwide, with the aim of providing broad viral protection and reducing the risk of future pandemics.
Reports state the vaccine is designed to stimulate immunity against multiple coronavirus types, covering not only every COVID-19 variant but also coronaviruses found in animals that could potentially cross species to humans and cause new pandemics in the future.
Published in the Journal of Infection, the research indicates that the immune response is currently at a "moderate" level. However, many experts view this as a significant milestone in vaccine development. Initial trials involving 39 volunteers primarily assessed safety, while the next phase, with about 200 participants, aims to better understand the vaccine's effectiveness in stimulating the immune system.
Professor Jonathan Heaney, one of the lead researchers, explained that vaccine development often lags behind viral mutations, especially for COVID-19 and seasonal influenza, which require continual formula updates. Scientists are striving to get ahead of the virus, with the goal of creating vaccines that can address new strains before outbreaks occur.
Professor Saul Faust, who helped conduct some of the trials, stated that this technology holds great potential, particularly in rapidly changing viral situations. It could become a crucial tool for preparing against future pandemics. He sees AI as a game changer in vaccine development because it can more quickly predict immune responses, reducing development time and saving more lives. The success of AI-designed vaccine trials represents a key step toward creating broad and lasting immunity against various viruses in the future.
/sourceBBC